Novel ELISAs to measure total and phosphorylated tau in cerebrospinal fluid
- 23 March 2020
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 722, 134826
- https://doi.org/10.1016/j.neulet.2020.134826
Abstract
No abstract availableFunding Information
- Amyloidosis Research Committee Surveys and Research on Special Diseases
- Longevity Science Committee of the Ministry of Health and Welfare of Japan
- Scientific Research (19K07989, 18K07385)
- Ministry of Education, Science, and Culture of Japan
This publication has 28 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseThe New England Journal of Medicine, 2012
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain, 2011
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter studyNeurobiology of Aging, 2008
- Electrodiagnostic criteria for diagnosis of ALSClinical Neurophysiology, 2008
- Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP TechnologyClinical Chemistry, 2005
- Incidence of Traumatic Lumbar PunctureAcademic Emergency Medicine, 2003
- Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study groupNeurobiology of Aging, 2002
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995